Your browser doesn't support javascript.
loading
Humoral Responses Against Variants of Concern by COVID-19 mRNA Vaccines in Immunocompromised Patients.
Obeid, Michel; Suffiotti, Madeleine; Pellaton, Celine; Bouchaab, Hasna; Cairoli, Anne; Salvadé, Vanja; Stevenel, Caroline; Hottinger, Rosemary; Pythoud, Catherine; Coutechier, Lucie; Molinari, Laura; Trono, Didier; Ribi, Camillo; Gottardo, Raphael; Fenwick, Craig; Pascual, Manuel; Duchosal, Michel A; Peters, Solange; Pantaleo, Giuseppe.
Affiliation
  • Obeid M; Service of Immunology and Allergy, Departments of Medicine and Laboratory Medicine and Pathology, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
  • Suffiotti M; Service of Immunology and Allergy, Departments of Medicine and Laboratory Medicine and Pathology, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
  • Pellaton C; Service of Immunology and Allergy, Departments of Medicine and Laboratory Medicine and Pathology, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
  • Bouchaab H; Service of Medical Oncology, Department of Oncology, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
  • Cairoli A; Service and Central Laboratory of Hematology, Departments of Oncology and Laboratory Medicine and Pathology, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
  • Salvadé V; Service of Transplantation, Departments of Medicine and Surgery, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
  • Stevenel C; Service of Immunology and Allergy, Departments of Medicine and Laboratory Medicine and Pathology, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
  • Hottinger R; Service of Immunology and Allergy, Departments of Medicine and Laboratory Medicine and Pathology, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
  • Pythoud C; Service of Immunology and Allergy, Departments of Medicine and Laboratory Medicine and Pathology, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
  • Coutechier L; Service of Medical Oncology, Department of Oncology, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
  • Molinari L; Service of Immunology and Allergy, Departments of Medicine and Laboratory Medicine and Pathology, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
  • Trono D; Laboratory of Virology and Genetics, EPFL, Lausanne, Switzerland.
  • Ribi C; Service of Immunology and Allergy, Departments of Medicine and Laboratory Medicine and Pathology, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
  • Gottardo R; Service of Data Science and Bioinformatics, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
  • Fenwick C; Service of Immunology and Allergy, Departments of Medicine and Laboratory Medicine and Pathology, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
  • Pascual M; Service of Transplantation, Departments of Medicine and Surgery, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
  • Duchosal MA; Service and Central Laboratory of Hematology, Departments of Oncology and Laboratory Medicine and Pathology, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
  • Peters S; Service of Medical Oncology, Department of Oncology, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
  • Pantaleo G; Service of Immunology and Allergy, Departments of Medicine and Laboratory Medicine and Pathology, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
JAMA Oncol ; 8(5): e220446, 2022 05 01.
Article de En | MEDLINE | ID: mdl-35271706

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Maladies auto-immunes / Tumeurs hématologiques / COVID-19 / Tumeurs Type d'étude: Observational_studies / Risk_factors_studies Limites: Aged / Female / Humans / Male / Middle aged Langue: En Journal: JAMA Oncol Année: 2022 Type de document: Article Pays d'affiliation: Suisse Pays de publication: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Maladies auto-immunes / Tumeurs hématologiques / COVID-19 / Tumeurs Type d'étude: Observational_studies / Risk_factors_studies Limites: Aged / Female / Humans / Male / Middle aged Langue: En Journal: JAMA Oncol Année: 2022 Type de document: Article Pays d'affiliation: Suisse Pays de publication: États-Unis d'Amérique